Therapeutic molecules & deviates for CRC
- 专利权人:
- 发明人:
- MANUEL GIDEKEL,Julio Alvarez Builla,Guillermo Mazzolini
- 申请号：
- US15236115
- 公开号：
- US20170049839A1
- 申请日:
- 2016.08.12
- 申请国别(地区):
- US
- 年份:
- 2017
- 代理人:
- 摘要：
- The chemically synthesized compound Tricin 7-O-beta-D-glucopyranoside, native to the plant Deschampsia Antarctica and present in aqueous extracts of the plant Deschampsia Antarctica said compound having the ability to inhibit tumor growth in mammals with colorectal carcinoma.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- MÉTHODES DE DÉTECTION PRÉCOCE DU CANCER COLORECTAL
- NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AND SCAFFOLDS THEREOF FOR USE IN IMMUNOTHERAPY AGAINST COLORECTAL CARCINOMA (CRC) AND OTHER CANCERS
- Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers
- Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers
- NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AND SCAFFOLDS THEREOF FOR USE IN IMMUNOTHERAPY AGAINST COLORECTAL CARCINOMA (CRC) AND OTHER CANCERS
